Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

StableVax

Financiado

Cerrado

Commercialisation of a world changing invention for the stabilisation and delive...

Commercialisation of a world changing invention for the stabilisation and delivery of vaccines Vaccination is an indispensable tool in fighting disease, annually saving up tens of millions of lives saved across the globe. Vaccines are biological products that are sensitive to temperature change and can lose their effectiven... ver más

31/10/2015

Stablepharma

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

STABLEPHARMA LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-10-31

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Stablepharma

50.00K€ | Lider

Proyectos interesantes

GLOBEVAC

Medical Technol...

Biotechnology

150K€ Cerrado

MACIVIVA

Medical Technol...

Nanotechnology

8M€ Cerrado

VERITASCAN

Medical Technol...

Electronics

150K€ Cerrado

NUEVA VACUNA CLOSTRIDIAL POLIVALENTE UTILIZA...

Medical Technol...

Biotechnology

813K€ Cerrado

FORMBECC

Medical Technol...

Materials Scien...

71K€ Cerrado

PolyVac

Medical Technol...

Biotechnology

173K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 2 meses Fecha Inicio: 2015-08-24
Fecha Fin: 2015-10-31

Líder del proyecto

STABLEPHARMA LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Vaccination is an indispensable tool in fighting disease, annually saving up tens of millions of lives saved across the globe. Vaccines are biological products that are sensitive to temperature change and can lose their effectiveness if exposed to sub optimum temperatures. The delivery of vaccines from the factory to the customer currently relies on a closely monitored cold chain process containing a series of refrigerated storage units, designed to keep the vaccine at a constant temperature. The system frequently fails for a variety of reasons, some technical and some simply due to human error. Currently 50% of the world’s vaccines are rendered useless due to the failings of the present refrigerated ‘cold chain’ delivery systems Stablepharma has a vision to eliminate the global cold chain and unnecessary vaccine wastage by introducing an innovative method to stabilise vaccines allowing them to be transported and stored at a wide-range of temperatures. Our technology involves the ~100% removal of liquid from vaccine dissolved in a special buffer, so that it is left in a completely stable and finely divided dry state absorbed into a, compressible, porous material that is in turn inserted into a standard auto-disable syringe. The process and invention was introduced to the WHO (World Health Organisation, Geneva) by invitation in 2012 and they have been able to assist the company with guidance in the development and accreditation process. Stablepharma Ltd was incorporated in January 2012 to commercialise a revolutionary vaccine stabilisation invention and process developed and patented by our Chief Scientific Officer (CSO) and Chairman, Dr Bruce Roser, a pioneer and distinguished scientist in this field.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores